A first-in-human Phase 1 Study to evaluate the Safety, Tolerability, and Immunogenicity of PVX-001, an mRNA vaccine against SARS-CoV-2, as a Booster in Healthy Adults

Authors
Category Primary study
Registry of TrialsAustralian New Zealand Clinical Trials Registry
Year 2026
This article has no abstract
Epistemonikos ID: f6220c6da297555800d04e9dccc43fd2ece04247
First added on: Jul 20, 2026